...
首页> 外文期刊>American Journal of Physiology >Surfactant protein D increases phagocytosis and aggregation of pollen-allergen starch granules.
【24h】

Surfactant protein D increases phagocytosis and aggregation of pollen-allergen starch granules.

机译:表面活性剂蛋白D增加了花粉过敏原淀粉颗粒的吞噬作用和聚集。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Recent studies have shown that surfactant components, in particular the collectins surfactant protein (SP)-A and -D, modulate the phagocytosis of various pathogens by alveolar macrophages. This interaction might be important not only for the elimination of pathogens but also for the elimination of inhaled allergens and might explain anti-inflammatory effects of SP-A and SP-D in allergic airway inflammation. We investigated the effect of surfactant components on the phagocytosis of allergen-containing pollen starch granules (PSG) by alveolar macrophages. PSG were isolated from Dactylis glomerata or Phleum pratense, two common grass pollen allergens, and incubated with either rat or human alveolar macrophages in the presence of recombinant human SP-A, SP-A purified from patients suffering from alveolar proteinosis, a recombinant fragment of human SP-D, dodecameric recombinant rat SP-D, or the commercially available surfactant preparations Curosurf and Alveofact. Dodecameric rat recombinant SP-D enhanced binding and phagocytosis of the PSG by alveolar macrophages, whereas the recombinant fragment of human SP-D, SP-A, or the surfactant lipid preparations had no effect. In addition, recombinant rat SP-D bound to the surface of the PSG and induced aggregation. Binding, aggregation, and enhancement of phagocytosis by recombinant rat SP-D was completely blocked by EDTA and inhibited by d-maltose and to a lesser extent by d-galactose, indicating the involvement of the carbohydrate recognition domain of SP-D in these functions. The modulation of allergen phagocytosis by SP-D might play an important role in allergen clearance from the lung and thereby modulate the allergic inflammation of asthma.
机译:最近的研究表明,表面活性剂组分,特别是collectins表面活性剂蛋白(SP)-A和-D,可调节肺泡巨噬细胞对各种病原体的吞噬作用。这种相互作用不仅对于消除病原体很重要,而且对于消除吸入的过敏原也很重要,并且可以解释SP-A和SP-D在过敏性气道炎症中的抗炎作用。我们调查了表面活性剂成分对肺泡巨噬细胞吞噬含变应原的花粉淀粉颗粒(PSG)的吞噬作用。从两种常见的草粉花粉过敏原Dactylis glomerata或Phleum pratense中分离PSG,并在重组人SP-A存在下将其与大鼠或人肺泡巨噬细胞一起孵育,SP-A从患有肺泡蛋白沉着症的患者纯化的SP-A重组片段人SP-D,十二聚体重组大鼠SP-D或市售的表面活性剂制剂Curosurf和Alveofact。十二聚体大鼠重组SP-D增强了肺泡巨噬细胞对PSG的结合和吞噬作用,而人SP-D,SP-A或表面活性剂脂质制剂的重组片段则没有作用。另外,重组大鼠SP-D结合到PSG的表面并诱导聚集。重组大鼠SP-D的结合,聚集和吞噬作用增强被EDTA完全阻断,并被d-麦芽糖抑制,并在较小程度上被d-半乳糖抑制,这表明SP-D的碳水化合物识别结构域参与了这些功能。 SP-D调节变应原吞噬作用可能在从肺中清除变应原中起重要作用,从而调节哮喘的变应性炎症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号